BETTING ON DRUG TRIALS AND APPROVALS PROMPTS CONCERNS ABOUT UNDERMINING RESEARCH

Summary from the TLDR newsletter

Kalshi and Polymarket now offer wagers on whether the FDA will approve medicines and whether drug trials will succeed.